---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-015318"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2023-03-31T23:59:59+00:00"
generated_at: "2026-06-17T07:43:50.416579+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# SANUWAVE Health restates 2022 quarterly financials; Audit Committee finds accounting errors

## Summary
- Audit Committee concluded Q1-Q3 2022 interim financials should no longer be relied upon due to misstatements.
- Errors: inventory conversion error (Q3), unaccrued professional fees (all Q), advisory shares (Q2), interest expense on NH Expansion Credit Fund note (all Q), improper lease accounting (Q1-Q2).
- Restated interim financials will be filed in FY2022 10-K; independent auditor Marcum LLP consulted.

## SEC filing metadata
- accession: 0001140361-23-015318
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2023-03-31T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 4.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000114036123015318/0001140361-23-015318-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000114036123015318/brhc10050692_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-015318
- JSON: https://secwatch.observer/filing/0001140361-23-015318.json
- Plain text: https://secwatch.observer/filing/0001140361-23-015318.txt

## Key facts
- Auditor Changes
  SANUWAVE Health, Inc. reported that prior financial statements should not be relied upon.
  - Action: non reliance
  - Auditor: Marcum LLP
  source text: On March 28, 2023, the Audit Committee of the Board of Directors (the "Audit Committee") of SANUWAVE Health, Inc. (the "Company") after discussion with management concluded that the interim financial statements contained in the Company's Quarterly Reports on Form 10-Q for the quarters ended March 31, 2022, June 30, 2022 and September 30, 2022 (the "Form 10-Qs") should no longer be relied upon
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417663/000114036123015318/0001140361-23-015318-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.